Ivonne Wieland studied Human medicine at the Carl Gustav Carus University Hospital at TU Dresden. She completed her studies in 2001. In 2005, she completed her doctorate on the significance of somatic mutations of the tumor suppressor gene PTEN/MMAC1/TEP1 in brain metastases, glioblastomas and neuroblastomas. Her work was awarded the Carl Gustav Carus Prize for outstanding doctoral theses.
She completed her specialist training at the pediatric clinic of Hannover Medical School, where she graduated in 2009 as a specialist in pediatric and adolescent medicine. In addition to pediatric hematology and oncology, Dr. Wieland gained many years of experience in pediatric intensive care medicine. Since 2003, her clinical and scientific focus has been on hemostaseology (coagulation). She also has experience in the outpatient, inpatient and perioperative care of children with coagulation disorders in this field.
Dr. Wieland is scientifically involved in the "Inhibitor Immunology Study" (multicentre study) with the characterization of immune mechanisms and T-cell activation in the development of inhibitors against coagulation factor VIII in the murine model as well as the characterization of genetic polymorphisms of genes associated with the immune response. She also studies acquired coagulation disorders in children, e.g. von Willebrand syndrome, and is interested in interdisciplinary problems in hemostaseology (e.g. intensive care medicine).
Dr. Wieland is a member of the Society for Pediatric Hematology and Oncology (GPOH), the Society for Thrombosis and Hemostasis Research (GTH) and the German Society for Pediatric and Adolescent Medicine (DGKJ).